COVID-19 risk perceptions in Japan: a cross-sectional study.

Publication date: Jul 23, 2024

We conducted a large-scale online survey in February 2023 to investigate the public’s perceptions of COVID-19 infection and fatality risks in Japan. We identified two key findings. First, univariate analysis comparing perceived and actual risk suggested overestimation and nonnegligible underestimation of COVID-19 risk. Second, multivariate logistic regression analyses revealed that age, income, education levels, health status, information sources, and experiences related to COVID-19 were associated with risk perceptions. Given that risk perceptions are closely correlated with daily socioeconomic activities and well-being, it is important for policy-makers and public health experts to understand how to communicate COVID-19 risk to the public effectively.

Open Access PDF

Concepts Keywords
Covid Adolescent
Education Adult
Fatality Aged
February COVID-19
Japan Cross-Sectional Studies
Female
Humans
Japan
Male
Middle Aged
Perception
SARS-CoV-2
Surveys and Questionnaires
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH education levels
disease MESH Long Covid
drug DRUGBANK Coenzyme M
disease VO effectiveness
disease VO population
disease VO time
disease IDO history
disease MESH chronic diseases
disease VO frequency
disease VO company
disease MESH malignant neoplasms
disease MESH cerebrovascular diseases
disease MESH cerebral hemorrhage
disease MESH cerebral infarction
disease MESH respiratory system diseases
disease MESH cardiovascular diseases
disease MESH myocardial infarction
disease MESH gastrointestinal diseases
disease VO stomach
disease MESH endocrine system diseases
disease MESH kidney diseases
disease MESH hematological diseases
disease MESH anemia
disease VO vaccination
drug DRUGBANK Aspartame
disease VO USA
drug DRUGBANK Pentaerythritol tetranitrate
disease VO vaccine
disease VO effective
drug DRUGBANK Trestolone
drug DRUGBANK Esomeprazole
drug DRUGBANK Carboxyamidotriazole
disease VO organ
drug DRUGBANK Silver
disease VO Optaflu
drug DRUGBANK Activated charcoal
disease MESH coronavirus infections
disease IDO facility
disease MESH Infectious Diseases

Original Article

(Visited 2 times, 1 visits today)